Biocon Biologics gets EU nod for bone disease treatments, including Osteoporosis, giant cell tumour of bone Ruchika Sharma3 July 2025 11:29 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced that the...
Biocon Biologics Yesafili gets Health Canada nod for eye diseases Ruchika Sharma27 Jun 2025 11:36 AM ISTYESAFILI is the first biosimilar to EYLEA to be approved by Health Canada.
Biocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India Dr. Divya Colin25 Jun 2025 4:51 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control Organisation (CDSCO),...
Biocon concludes Rs 4500 crore equity fundraise through QIP Ruchika Sharma21 Jun 2025 11:30 AM ISTBengaluru: Biocon Limited, a global biopharmaceutical company, has announced the successful completion of a Qualified Institutions...
Biocon Foundation in collaboration with BeST Cluster, NCBS introduces BioWISE Program - to Empower Women in STEM Ruchika Sharma10 Jun 2025 1:11 PM ISTBengaluru: Biocon Foundation, the Corporate Social Responsibility arm of Biocon Group, in collaboration with The Bengaluru Science and...
CDSCO approves Biocon diabetes drug Liraglutide Ruchika Sharma3 Jun 2025 11:51 AM ISTLiraglutide is a synthetic analog of GLP-1 peptide and is administered as a once-daily injection.
Biocon arm gets marketing nod in UK for plaque psoriasis drug Yesintek Ruchika Sharma26 May 2025 11:37 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has...
Malaysia extends Insulins supply contract with Biocon Biologics arm, Duopharma Marketing for additional 6 months Ruchika Sharma22 May 2025 11:30 AM ISTBengaluru: Biocon Biologics Limited has announced that the Government of Malaysia has agreed to extend the current contract period of 36 months...
Biocon Biologics commercial partner launches psoriatic arthritis injection in Japan Ruchika Sharma21 May 2025 12:29 PM ISTUstekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis.
Biocon Pharma gets USFDA nod for deep vein thrombosis drug Rivaroxaban Ruchika Sharma16 May 2025 2:57 PM ISTBangalore: Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval for its Abbreviated New Drug...
Biocon posts more than twofold increase in Q4 profit Ruchika Sharma9 May 2025 2:30 PM ISTBengaluru: Biocon, an Indian biopharmaceutical company, has reported a more than twofold increase in its fourth-quarter profit, driven by robust...
Biocon Biologics secures multiple market access agreements in US for Yesintek Ruchika Sharma5 May 2025 12:50 PM ISTYESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.
